Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Tandem Diabetes Care (TNDM) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for Tandem Diabetes Care (TNDM) over the last 13 years, with Q3 2025 value amounting to -$0.31.

  • Tandem Diabetes Care's EPS (Basic) rose 1142.86% to -$0.31 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.05, marking a year-over-year decrease of 5803.11%. This contributed to the annual value of -$1.46 for FY2024, which is 5754.31% up from last year.
  • As of Q3 2025, Tandem Diabetes Care's EPS (Basic) stood at -$0.31, which was up 1142.86% from -$0.78 recorded in Q2 2025.
  • Over the past 5 years, Tandem Diabetes Care's EPS (Basic) peaked at $0.17 during Q4 2021, and registered a low of -$1.97 during Q1 2025.
  • Moreover, its 5-year median value for EPS (Basic) was -$0.35 (2024), whereas its average is -$0.48.
  • In the last 5 years, Tandem Diabetes Care's EPS (Basic) surged by 15866.73% in 2021 and then plummeted by 94444.44% in 2022.
  • Over the past 5 years, Tandem Diabetes Care's EPS (Basic) (Quarter) stood at $0.17 in 2021, then plummeted by 244.65% to -$0.25 in 2022, then tumbled by 86.13% to -$0.46 in 2023, then soared by 102.56% to $0.01 in 2024, then crashed by 2737.56% to -$0.31 in 2025.
  • Its EPS (Basic) was -$0.31 in Q3 2025, compared to -$0.78 in Q2 2025 and -$1.97 in Q1 2025.